Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Efficacy and Safety of Low Molecular Weight Iron Dextran (LMWID) Vs. Ferumoxytol in Treating Iron Deficiency Anemia

Arpine Khudanyan, BS, Sven Reid Olson, MD, Thomas G. Deloughery, MD, Joseph J Shatzel, MD

Blood (2019) 134 (Supplement_1): 2449.

https://doi.org/10.1182/blood-2019-129653

Published: 2019

Journal Articles

Impact of Parenteral Iron Therapy on Hemoglobin Normalization: A Retrospective Analysis

Chris LaVallee, M.S, Patrick Cronin, M.A, Isha Bansal, M.S, Jackie Kwong, PhD PharmD, Ralph Boccia, MD

Blood (2019) 134 (Supplement_1): 3445.

https://doi.org/10.1182/blood-2019-125793

Published: 2019

Journal Articles

A Fully Human Anti-BMP6 Antibody Reduces the Need for Erythropoietin Stimulating Agent in Two Rodent Anemia of Chronic Disease Models

Verena Petzer, MD, Piotr Tymoszuk, PhD, Matthew Wake, PhD, Luke Bayliss, BSc, Jonathan Papworth, BSc, Joana Carvalho, PhD, Cecilia Deantonio, PhD, Malte Ferdinand Asshoff, MD, Markus Seifert, Sylvia Berger, Dominik Wolf, MD, Günter Weiss, MD, Volker Germaschewski, PhD, Igor Theurl, MD PhD

Blood (2018) 132 (Supplement 1): 1045.

https://doi.org/10.1182/blood-2018-99-115747

Published: 2018

Journal Articles

Microcytic Anemia and Celiac Disease Preceding Pulmonary Symptoms in Lane-Hamilton Syndrome

Robert Szulawski, DO, Catherine D Quinn, MD, Eric Safyan, MD

Blood (2017) 130 (Supplement 1): 4753.

https://doi.org/10.1182/blood.V130.Suppl_1.4753.4753

Published: 2017

Journal Articles

Iron Malabsorption Associated with Elevated Serum Gastrin

Michael Boxer, MD

Blood (2015) 126 (23): 3364.

https://doi.org/10.1182/blood.V126.23.3364.3364

Published: 2015

Journal Articles

Ambulatory Management of Anemia: A Retrospective View from an Italian Multidisciplinary Team

Eleonora Arboscello, MD, Elisa Molinari, MD, Francesco Tolomeo, MD, Lisette Del Corso, MD, Luana Vignolo, MD, Gianluca Ubezio, MD, Paolo Carlier, MD, Paolo Strada, MD, Riccardo Ghio, PhD, Francesco Puppo, PhD, Paola Mangini, MD, Sabrina Beltramini, MD, Pietro Dulbecco, MD, Paola Anserini, MD, Maria Teresa van Lint, MD, Andrea Bacigalupo, MD, Fabio Guolo, MD, Marino Clavio, MD, Andrea Bellodi, MD

Blood (2015) 126 (23): 5583.

https://doi.org/10.1182/blood.V126.23.5583.5583

Published: 2015

Journal Articles

Iron Supplementation Adjunct to Erythropoiesis Stimulating Agents Is Cost Saving for Chemotherapy-Related Anemia in the Era of Biosimilars

Monia Marchetti, MD PhD, Giovanni Barosi, MD, Paolo Pedrazzoli

Blood (2014) 124 (21): 2165.

https://doi.org/10.1182/blood.V124.21.2165.2165

Published: 2014

Journal Articles

Efficacy of Total Dose Administration (TDI) of 1012 Mg of Ferumoxytol Over 15 Minutes for the Treatment of Iron Deficient Anemia

Michael Auerbach, MD, William Strauss, M.D., F.A.C.C., Sarah Auerbach, Stella Rineer, Huzefa Bahrain

Blood (2012) 120 (21): 3204.

https://doi.org/10.1182/blood.V120.21.3204.3204

Published: 2012

Journal Articles

A Retrospective Comparison of Adverse Reaction Rates with the Use of Three Intravenous Iron Formulations: A Single Center Experience.

Maureen Okam, MD, Elyse Mandell, ANP

Blood (2010) 116 (21): 1537.

https://doi.org/10.1182/blood.V116.21.1537.1537

Published: 2010

Journal Articles

Efficiency Outcomes Associated with Increased Ferumoxytol Use In An Infusion Clinic

Michael Meyers, Erik Erdal, Christpoher Khan, Amy McKee, Betsy Lahue

Blood (2010) 116 (21): 5151.

https://doi.org/10.1182/blood.V116.21.5151.5151

Published: 2010

Journal Articles

A Head-to-Head Comparison of the Safety and Efficacy of Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia

Allen Poma, MD, MBA, Karen Diana, MS, Justin McLaughlin, MA, Annamaria Kausz, MD, MS

Blood (2010) 116 (21): 5157.

https://doi.org/10.1182/blood.V116.21.5157.5157

Published: 2010

Journal Articles

Intravenous Iron Supplementation for the Treatment of Cancer-Related Anemia – Systematic Review and Meta-Analysis

Anat Gafter-Gvili, MD, Benaya Rozen-Zvi, MD, Liat Vidal, MD, Uzi Gafter, MD, PHD, Johan F. Vansteenkiste, MD, Ofer Shpilberg, MD, MPH

Blood (2010) 116 (21): 4249.

https://doi.org/10.1182/blood.V116.21.4249.4249

Published: 2010

Journal Articles

Is There a Difference in the Preclinical Safety Parameters of Different Intravenous Iron Compounds?.

Jorge Toblli, MD, PhD, FASN, Gabriel Cao, MD, Leda Oliveri, PhD, Margarita Angerosa, PhD

Blood (2009) 114 (22): 5097.

https://doi.org/10.1182/blood.V114.22.5097.5097

Published: 2009

Journal Articles

A Phase III, Randomized Study of the Effects of Parenteral Iron, Oral Iron, or No Iron Supplementation On the Erythropoietic Response to Darbepoetin Alfa for Patients with Chemotherapy-Associated Anemia: A Study of the Mayo Clinic Cancer Research Consortium (MCCRC).

David P Steensma, MD, Shaker R. Dakhil, MD, Robert Dalton, MD, Stephen P Kahanic, MD, John W Kugler, MD, Philip J Stella, MD, Kendrith M Rowland, Jr., MD, Paul J Novotny, MS, Jeff A Sloan, PhD, Charles L Loprinzi, MD

Blood (2009) 114 (22): 630.

https://doi.org/10.1182/blood.V114.22.630.630

Published: 2009

Journal Articles

Manageable Side Effects of Intravenous Iron in a Community Practice

Nicole Brown, BA, David H. Henry, MD, Patricia A. Ford, MD

Blood (2008) 112 (11): 4687.

https://doi.org/10.1182/blood.V112.11.4687.4687

Published: 2008

Journal Articles

Is Thromboembolism in Cancer Patients Treated with Erythropoietic Stimulating Agents Related to Thrombocytosis and Iron Restricted Erythropoiesis?.

David H. Henry, MD, Naomi V. Dahl, PharmD, Michael Auerbach, MD

Blood (2007) 110 (11): 1625.

https://doi.org/10.1182/blood.V110.11.1625.1625

Published: 2007

Journal Articles

Sepsis Following Parenteral Sodium Ferric Gluconate Complex Infusion: A Report of Two Cases and Literature Review.

Tufia C. Haddad, MD, Raj S. Kasthuri, MBBS, Gregory M. Vercellotti, MD

Blood (2006) 108 (11): 3729.

https://doi.org/10.1182/blood.V108.11.3729.3729

Published: 2006

Journal Articles

Safety Profile of Iron Carboxymaltose, a New High Dose Intravenous Iron in Patients with Iron Deficiency Anemia.

Melvin H. Seid, MD, Antoinette Mangione, MD,PharmD, Thomas G. Valaoras, MD, Lowell B. Anthony, MD, Charles F. Barish, MD

Blood (2006) 108 (11): 3739.

https://doi.org/10.1182/blood.V108.11.3739.3739

Published: 2006

Journal Articles

Efficacy and Tolerability of Intravenous Ferric Sodium Gluconate in the Treatment of Iron Deficiency Anemia in Non-Kidney Disease Patients.

Heather J. Miller, MD, James S. Hu, MD, Preston S. Gable, MD

Blood (2005) 106 (11): 1683.

https://doi.org/10.1182/blood.V106.11.1683.1683

Published: 2005

Journal Articles

A Community Cancer Center Experience of the Efficacy and Safety of the Use of Intravenous Iron Dextran in Chemotherapy Induced Anemia.

Kaushik Sen, MD, Ngozi O. Okoro, MD, Theresa R. Hedman, RN

Blood (2004) 104 (11): 3676.

https://doi.org/10.1182/blood.V104.11.3676.3676

Published: 2004

NARROW

Efficacy and Safety of Low Molecular Weight Iron Dextran (LMWID) Vs. Ferumoxytol in Treating Iron Deficiency Anemia

Impact of Parenteral Iron Therapy on Hemoglobin Normalization: A Retrospective Analysis

A Fully Human Anti-BMP6 Antibody Reduces the Need for Erythropoietin Stimulating Agent in Two Rodent Anemia of Chronic Disease Models

Microcytic Anemia and Celiac Disease Preceding Pulmonary Symptoms in Lane-Hamilton Syndrome

Iron Malabsorption Associated with Elevated Serum Gastrin

Ambulatory Management of Anemia: A Retrospective View from an Italian Multidisciplinary Team

Iron Supplementation Adjunct to Erythropoiesis Stimulating Agents Is Cost Saving for Chemotherapy-Related Anemia in the Era of Biosimilars

Efficacy of Total Dose Administration (TDI) of 1012 Mg of Ferumoxytol Over 15 Minutes for the Treatment of Iron Deficient Anemia

A Retrospective Comparison of Adverse Reaction Rates with the Use of Three Intravenous Iron Formulations: A Single Center Experience.

Efficiency Outcomes Associated with Increased Ferumoxytol Use In An Infusion Clinic

A Head-to-Head Comparison of the Safety and Efficacy of Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia

Intravenous Iron Supplementation for the Treatment of Cancer-Related Anemia – Systematic Review and Meta-Analysis

Is There a Difference in the Preclinical Safety Parameters of Different Intravenous Iron Compounds?.

A Phase III, Randomized Study of the Effects of Parenteral Iron, Oral Iron, or No Iron Supplementation On the Erythropoietic Response to Darbepoetin Alfa for Patients with Chemotherapy-Associated Anemia: A Study of the Mayo Clinic Cancer Research Consortium (MCCRC).

Manageable Side Effects of Intravenous Iron in a Community Practice

Is Thromboembolism in Cancer Patients Treated with Erythropoietic Stimulating Agents Related to Thrombocytosis and Iron Restricted Erythropoiesis?.

Sepsis Following Parenteral Sodium Ferric Gluconate Complex Infusion: A Report of Two Cases and Literature Review.

Safety Profile of Iron Carboxymaltose, a New High Dose Intravenous Iron in Patients with Iron Deficiency Anemia.

Efficacy and Tolerability of Intravenous Ferric Sodium Gluconate in the Treatment of Iron Deficiency Anemia in Non-Kidney Disease Patients.

A Community Cancer Center Experience of the Efficacy and Safety of the Use of Intravenous Iron Dextran in Chemotherapy Induced Anemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only